Preliminary Agenda Published

The preliminary agenda for the Cord Blood Connect international congress has been published on the CBA website.

The agenda provides a wide spectrum of content for everyone in the cord blood community, whether their interest is advances in therapies or in-service training and education.

Most of the scientific and technical sessions are in concurrent tracks. so registrants can choose the topics most pertinent to their interests.  Strategies for participant interaction, idea exchange and networking are being woven into the congress structure.

Early registrations have been strong and, as anticipated, industry partners are stepping forward with major support:

   Cord Blood Registry/AMAG Pharmaceuticals

   Sino Cell Technologies
   PerkinElmer Viacord

  Gamida Cell
  Magenta Therapeutics
  National Marrow Donor Program

The enthusiastic corporate support is helping to keep registration fees low so that cord blood banks and organizations can send teams of staff to the congress.